NCT00230464View on ClinicalTrials.gov

Acute Metabolic Effects of LAF 237 in Type 2 Diabetics

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

September 30, 2005

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LAF 237

Trial Locations (1)

78229

Audie L Murphy VA Hospital, San Antonio

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER